QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,937 signal articles · 507 in last 24h · 106,168 total before filter · latest 19m ago
507last 24h
2477last 7d
484● bullish (7d)
254● bearish (7d)
200publishers
AllMacro169Earnings1549M&A138Regulatory15Product8Analyst21
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Sanofi Q2 Earnings Call Highlights
MarketBeat7d agoneutral
Sanofi Q2 Earnings Call Highlights

Sanofi (NASDAQ:SNY) raised its 2026 outlook after reporting double-digit second-quarter sales and earnings growth, driven by Dupixent, recently launched medicines and cost discipline. The company also increased its 2030 sales ambition for Dupixent to approximately €25 billion while outlining an ongo